Prediction of Cancer Specific Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Development of an Optimized Postoperative Nomogram Using Decision Curve Analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lughezzani, 2010, Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature, Eur Urol, 58, 687, 10.1016/j.eururo.2010.07.034
Rouprêt, 2011, European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update, Eur Urol, 59, 584, 10.1016/j.eururo.2010.12.042
Ariane, 2012, Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study, Ann Surg Oncol, 19, 301, 10.1245/s10434-011-1841-x
Margulis, 2009, Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration, Cancer, 115, 1224, 10.1002/cncr.24135
Cha, 2012, Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma, Eur Urol, 61, 818, 10.1016/j.eururo.2012.01.021
Yates, 2012, Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram, Br J Cancer, 106, 1083, 10.1038/bjc.2012.64
Xylinas, 2012, Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma, Eur Urol, 10.1016/j.eururo.2012.04.052
Greene, 2002
Epstein, 1998, The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee, Am J Surg Pathol, 22, 1435, 10.1097/00000478-199812000-00001
Ouzzane, 2011, Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy, Eur Urol, 60, 1258, 10.1016/j.eururo.2011.05.049
Remzi, 2009, Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients, BJU Int, 103, 307, 10.1111/j.1464-410X.2008.08003.x
Kikuchi, 2009, Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma, J Clin Oncol, 27, 612, 10.1200/JCO.2008.17.2361
Harrell, 1996, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors, Stat Med, 15, 361, 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
Efron, 1993, An Introduction to the Bootstrap, 275
Harrell
Vickers, 2008, Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers, Am Stat, 62, 314, 10.1198/000313008X370302
Vickers, 2006, Decision curve analysis: a novel method for evaluating prediction models, Med Decis Making, 26, 565, 10.1177/0272989X06295361
Stephenson, 2006, Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy, J Natl Cancer Inst, 98, 715, 10.1093/jnci/djj190
Klatte, 2010, Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma, J Urol, 184, 53, 10.1016/j.juro.2010.03.026
Nguyen, 2011, How to tell if a new marker improves prediction, Eur Urol, 60, 226, 10.1016/j.eururo.2011.04.029
Chromecki, 2012, The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy, Eur Urol, 61, 245, 10.1016/j.eururo.2011.09.017
Isbarn, 2009, Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma, J Urol, 182, 2177, 10.1016/j.juro.2009.07.035
Lughezzani, 2012, Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature, Eur Urol, 62, 100, 10.1016/j.eururo.2012.02.030
Hong, 2012, Predictive power to assist phase 3 go/no go decision based on phase 2 data on a different endpoint, Stat Med, 31, 831, 10.1002/sim.4476
Miller, 2005, How modeling and simulation have enhanced decision making in new drug development, J Pharmacokinet Pharmacodyn, 32, 185, 10.1007/s10928-005-0074-7